KATIE M CALLIS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family KANSAS CITY, MO NPI 1639736770

General Payments — all program years on this page

$2,802.15

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,151.11 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,151.1119

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $645.779
Acerta Pharma LLC $179.274
Janssen Scientific Affairs, LLC $161.662
UCB, Inc. $144.103
ANI Pharmaceuticals, Inc. $20.311

By program year

Program yearAmountRecords
2021 $734.7724
2022 $401.7216
2023 $514.558
2024 $1,151.1119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078853086 Janssen Scientific Affairs, LLC $63.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078853092 Janssen Scientific Affairs, LLC $98.66 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091169186 ANI Pharmaceuticals, Inc. $20.31 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104264875 AstraZeneca Pharmaceuticals LP $23.25 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104449713 AstraZeneca Pharmaceuticals LP $30.46 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105452381 AstraZeneca Pharmaceuticals LP $21.93 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105893512 AstraZeneca Pharmaceuticals LP $103.63 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216116 Amgen Inc. $5.88 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117216118 Amgen Inc. $6.81 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519549 Amgen Inc. $119.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519551 Amgen Inc. $119.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519553 Amgen Inc. $16.62 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519555 Amgen Inc. $151.44 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519557 Amgen Inc. $7.81 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519559 Amgen Inc. $115.46 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117519561 Amgen Inc. $102.39 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143059741 UCB, Inc. $16.34 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143059743 UCB, Inc. $57.90 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143059745 UCB, Inc. $69.86 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.